뉴트라슈티컬 구미 시장 예측(-2030년) : 유형별, 소비자 유형별, 생산능력별, 원료 유래별, 구미 기반/부형제별, 제품 유형별, 기능성별, 인구통계별, 유통 채널별, 지역별

The nutraceutical gummies market is estimated at USD 24.39 billion in 2025 and is projected to reach USD 47.80 billion by 2030, at a CAGR of 14.4%. The global nutraceutical gummies market is experiencing significant growth, driven by rising rates of vitamin deficiency and undernutrition, a growing focus on preventive health and wellness, rising consumer interest in beauty and wellness, expanding e-commerce and DTC channels, and an increasing preference for the gummy delivery format over traditional pills and capsules. Additionally, growth in plant-based and sugar-free gummies, increasing reliance of startups and D2C brands on turnkey contract manufacturing, and geographic expansion with localized formulation expertise are expected to create significant opportunities in the nutraceutical gummies market.

However, high production costs and ingredient stability issues, regulatory complexities across regions, and the complexity of maintaining batch-to-batch consistency and stability are expected to pose challenges in the nutraceutical gummies market. Furthermore, increasing audit expectations from global brand owners and intense market competition and brand differentiation also remain technical challenges.

"Immunity support function is expected to hold a dominant market share during the forecast period."

The popularity of nutraceutical gummies is growing because of their convenient form, size, and ease of consumption. The benefits of multivitamin gummies for boosting immunity also play a key role in the increased demand for nutraceutical gummies. Gummies offer the fastest growth potential for vitamin and mineral supplements. The market for immunity-specific gummy supplements is expected to grow as more people become aware of how nutrition affects their health and of the specific issues that can be addressed through lifestyle factors.

"The online channel segment in the B2C segment is expected to hold a significant market share among the sales channels in the nutraceutical gummies market."

With rising awareness, demand, and traction, nutraceutical gummies have become a mainstream market staple. The increase in demand for these products has led to a rise in sales across various countries and regions, facilitated by both online and offline distribution channels. Key players are increasingly adopting and navigating their investments in distribution channels to make their products available to a wider consumer base. In addition, nutraceutical gummies manufacturing companies are promoting their products in the market through strategies such as online retailing, a part of the non-store-based distribution channel, which is expected to drive demand.

"Europe is expected to hold a significant share in the global nutraceutical gummies market during the forecast period."

Companies operating in this region are also investing in expansions and acquisitions to meet the growing demand from the dietary supplements industry, including nutraceutical gummies. The growing demand for nutraceutical gummies in Europe is attributed to fast-paced lifestyles, health-conscious consumers, and urbanization. In 2020, Unilever acquired SmartyPants Vitamins, a US-based vitamin, mineral & supplement company. SmartyPants utilizes a range of sustainably sourced, bioavailable nutrients and non-GMO-certified ingredients. Its product line is free of artificial preservatives, sweeteners, colors, and flavors. This has made Unilever expand its product portfolio and serve more consumers in Europe.

In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the nutraceutical gummies market.

• By Company Type: Tier 1 - 25%, Tier 2 - 45%, and Tier 3 - 30%
• By Designation: CXOs - 25%, Managers - 40%, Others - 35%
• By Region: North America - 25%, Europe - 25%, Asia Pacific - 35%, South America - 10%, and Rest of the World -5%

Prominent companies in the market include-Brand Manufacturers: Church & Dwight Co., Inc. (US), H&H Group (Hong Kong), Amway (US), Bayer AG (Germany), Haleon (UK), Nestle (Switzerland), Unilever (US), Otsuka Holdings Co., Ltd. (Japan), PharmaCare Laboratories Australia (Australia), Swanson (US), IM Healthcare (India), SMP Nutra (US), Nature's Truth (US) and Herbaland Naturals Inc. (Canada) and Contract Manufacturers: Sofgen Pharma (Luxembourg), Catalent, Inc. ( US), Activ'Inside ( France), WinNutra (US), Makers Nutrition, LLC (US), Ion Labs (US), Vitajoy Group (China), Bliss Lifesciences LLP (India), Global Widget, LLC (US), Gummy Worlds (Turkey), TopGum (Israel), MeriCal (US), Fexmentis Life Sciences (India), and Eagle Labs, Inc. (US) among others.

Research Coverage

This research report categorizes the nutraceutical gummies market by type (B2B market and B2C market); customer type (B2B) (brand owners and marketing companies, retailers and distributors, healthcare and wellness providers, pharmaceutical companies, and food & beverage companies); production capacity (B2B) (small-scale contract manufacturers (< 10 m units/year), mid-scale manufacturers (10-50 m units/year), and large-scale industrial manufacturers (50 m+ units/year)); ingredient source (B2B) (animal-based source, plant-based source, microbial/fermentation-derived sources, and synthetic/chemically-derived sources); gummy base/excipients (B2B) (gelatin-based gummies, pectin-based gummies, starch-based gummies, agar, carrageenan, and other hydrocolloids); product type (B2C) (vitamins, minerals, omega-3 fatty acids, probiotics and prebiotics, collagen and beauty-from-within, herbal and botanical supplements, dietary fiber, CBD and cannabis-derived, and specialty formulations); functionality (B2C) (immunity support, general health & wellness, bone & joint health, weight management, beauty & skin health, and other functionalities); demographics (B2C) (generation alpha (0-12 years), generation Z (13-28 years), millennials (gen Y) (29-44 years), generation X (45-60 years), and baby boomers & older (61+ years)); sales channel (offline and online); and region (North America, Europe, Asia Pacific, South America, and Rest of the World).

The report's scope encompasses detailed information on the major factors, including drivers, restraints, challenges, and opportunities, which influence the growth of the nutraceutical gummies industry. A thorough analysis of key industry players has been conducted to provide insights into their businesses, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments in the nutraceutical gummies market. This report provides a competitive analysis of emerging startups in the nutraceutical gummies market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscape, among others.

Reasons to Buy This Report

The report provides market leaders/new entrants with information on the closest approximations of revenue numbers for the overall nutraceutical gummies and their subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

• Analysis of key drivers (increasing preference for gummy delivery format over traditional pills and capsules, driving production volume), restraints (ingredient sourcing volatility), opportunities (increasing reliance of startups and D2C brands on turnkey contract manufacturing), and challenges (increasing audit expectations from global brand owners), influencing the growth of the nutraceutical gummies market
• Product Development/Innovation: Detailed insights into research & development activities and new product launches in the nutraceutical gummies market
• Market Development: Comprehensive information about lucrative markets-analysis of nutraceutical gummies across varied regions
• Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the nutraceutical gummies market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as Brand Manufacturers: Church & Dwight Co., Inc. (US), H&H Group (Hong Kong), Amway (US), Bayer AG (Germany), Haleon (UK), Nestle (Switzerland), Unilever (US), Otsuka Holdings Co., Ltd. (Japan), PharmaCare Laboratories Australia (Australia), Swanson (US), IM Healthcare (India), SMP Nutra (US), Nature's Truth (US) and Herbaland Naturals Inc. (Canada) and Contract Manufacturers: Sofgen Pharma (Luxembourg), Catalent, Inc. (US), Activ'Inside (France), WinNutra (US), Makers Nutrition, LLC (US), Ion Labs (US), Vitajoy Group (China), Bliss Lifesciences LLP (India), Global Widget, LLC (US), Gummy Worlds (Turkey), TopGum (Israel), MeriCal (US), Fexmentis Life Sciences (India), and Eagle Labs, Inc. (US), among other players in the nutraceutical gummies market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS AND EXCLUSIONS
• 1.3 STUDY SCOPE
• 1.4 YEARS CONSIDERED
• 1.5 CURRENCY CONSIDERED
• 1.6 UNIT CONSIDERED
• 1.7 STAKEHOLDERS

2 EXECUTIVE SUMMARY

• 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
• 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS IN NUTRACEUTICAL GUMMIES MARKET
• 2.4 HIGH GROWTH SEGMENTS
• 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN NUTRACEUTICAL GUMMIES MARKET
• 3.2 B2B NUTRACEUTICAL GUMMIES MARKET, BY PRODUCTION CAPACITY AND REGION
• 3.3 B2C NUTRACEUTICAL GUMMIES MARKET, BY PRODUCT TYPE AND REGION
• 3.4 B2B NUTRACEUTICAL GUMMIES MARKET, BY CUSTOMER TYPE
• 3.5 B2B NUTRACEUTICAL GUMMIES MARKET, BY INGREDIENT SOURCE
• 3.6 B2C NUTRACEUTICAL GUMMIES MARKET, BY DEMOGRAPHICS
• 3.7 B2B NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY
• 3.8 B2C NUTRACEUTICAL GUMMIES MARKET, BY COUNTRY

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Rising rate of vitamin-deficiency diseases and undernutrition
    • 4.2.1.2 Growing consumer interest in beauty and wellness
    • 4.2.1.3 Innovation in functional formulations
    • 4.2.1.4 Growth in gummy supplement launches and custom gummy programs
    • 4.2.1.5 Increasing preference for gummy delivery format over traditional pills and capsules
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 Regulatory complexities across regions
    • 4.2.2.2 Sugar content and health concerns
    • 4.2.2.3 Ingredient sourcing volatility
    • 4.2.2.4 Complexity in maintaining batch-to-batch consistency and stability
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Rising popularity of plant-based and sugar-free gummies
    • 4.2.3.2 Expansion into personalized and AI-driven nutrition
    • 4.2.3.3 Increasing reliance of startups and D2C brands on turnkey contract manufacturing
    • 4.2.3.4 Geographic expansion with localized formulation expertise
  • 4.2.4 CHALLENGES
    • 4.2.4.1 Limited bioavailability and nutrient degradation
    • 4.2.4.2 Intense market competition and brand differentiation
    • 4.2.4.3 Logistics issues: Melting, deformation, and transit stability
    • 4.2.4.4 Increasing audit expectations from global brand owners
• 4.3 UNMET NEEDS AND WHITE SPACES
  • 4.3.1 UNMET NEEDS IN NUTRACEUTICAL GUMMIES MARKET
  • 4.3.2 WHITE SPACE OPPORTUNITIES
• 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
  • 4.4.1 INTERCONNECTED MARKETS
  • 4.4.2 CROSS-SECTOR OPPORTUNITIES
• 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
  • 4.5.1 KEY MOVES AND STRATEGIC FOCUS

5 INDUSTRY TRENDS

• 5.1 PORTER'S FIVE FORCES ANALYSIS
  • 5.1.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.1.2 BARGAINING POWER OF SUPPLIERS
  • 5.1.3 BARGAINING POWER OF BUYERS
  • 5.1.4 THREAT OF SUBSTITUTES
  • 5.1.5 THREAT OF NEW ENTRANTS
• 5.2 MACROECONOMICS OUTLOOK
  • 5.2.1 INTRODUCTION
    • 5.2.1.1 Macroeconomic indicators - B2C market
      • 5.2.1.1.1 US-China trade tariff fluctuations reshape nutraceutical gummies market
      • 5.2.1.1.2 Inflation and raw material costs reshape nutraceutical gummies market
        • 5.2.1.1.2.1 Sweeteners and sugar inputs
        • 5.2.1.1.2.2 Gelling agents: Gelatin, pectin, and alternatives
        • 5.2.1.1.2.3 Vitamins, actives, flavors, and specialty additives
        • 5.2.1.1.2.4 Energy, transportation, and packaging inflation
    • 5.2.1.2 Macroeconomic indicators - B2B market
      • 5.2.1.2.1 Population aging and chronic disease burden influencing preventive health and nutraceutical market expansion
• 5.3 VALUE CHAIN ANALYSIS
  • 5.3.1 RAW MATERIAL & FUNCTIONAL INGREDIENT SOURCING
  • 5.3.2 PRODUCT DEVELOPMENT AND MANUFACTURING
  • 5.3.3 QUALITY, SAFETY, AND REGULATORY COMPLIANCE
  • 5.3.4 PACKAGING & LABEL CUSTOMIZATION
  • 5.3.5 MARKETING AND DISTRIBUTION
  • 5.3.6 END USERS
• 5.4 ECOSYSTEM ANALYSIS
  • 5.4.1 DEMAND SIDE
  • 5.4.2 SUPPLY SIDE
• 5.5 PRICING ANALYSIS
  • 5.5.1 AVERAGE SELLING PRICE (ASP) OF NUTRACEUTICAL GUMMIES, BY KEY PLAYER
  • 5.5.2 AVERAGE SELLING PRICE (ASP) TREND OF NUTRACEUTICAL GUMMIES, BY REGION
• 5.6 TRADE ANALYSIS
  • 5.6.1 EXPORT SCENARIO OF HS CODE 210690, BY KEY COUNTRY, 2020-2024 (MT)
  • 5.6.2 IMPORT SCENARIO OF HS CODE 210690, BY KEY COUNTRY, 2020-2024 (MT)
• 5.7 KEY CONFERENCES AND EVENTS, 2026-2027
• 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.9 INVESTMENT AND FUNDING SCENARIO
• 5.10 CASE STUDY ANALYSIS
  • 5.10.1 NESTLE HEALTH SCIENCE - EXPANDED COLLAGEN & FUNCTIONAL PORTFOLIO THROUGH MAJORITY STAKE ACQUISITION OF VITAL PROTEINS
  • 5.10.2 SIRIO PHARMA - EXPANDING NUTRACEUTICAL GUMMY AND PLANT-BASED SOFTGEL MANUFACTURING THROUGH ACQUISITION OF BEST FORMULATIONS
  • 5.10.3 TOPGUM INDUSTRIES - EXPANDING PHARMA GRADE AND HIGH VOLUME GUMMY MANUFACTURING THROUGH ACQUISITION OF ISLAND ABBEY NUTRITIONALS
  • 5.10.4 GILLCO/IFF GRINDSTED - ENHANCING GUMMY GELATION AND PROCESS STABILITY USING SLOW-SET PECTIN
• 5.11 IMPACT OF 2025 US TARIFF - NUTRACEUTICAL GUMMIES MARKET
  • 5.11.1 INTRODUCTION
  • 5.11.2 KEY TARIFF RATES
  • 5.11.3 PRICE IMPACT ANALYSIS
  • 5.11.4 IMPACT ON COUNTRIES/REGIONS
    • 5.11.4.1 US
    • 5.11.4.2 Europe
    • 5.11.4.3 Asia Pacific
  • 5.11.5 IMPACT ON END-USE INDUSTRIES

6 TECHNOLOGY ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 6.1 TECHNOLOGY ANALYSIS
  • 6.1.1 KEY TECHNOLOGIES
    • 6.1.1.1 Gelling and texture technology
      • 6.1.1.1.1 Starch-based gelling technology
      • 6.1.1.1.2 Starchless gelling technology
    • 6.1.1.2 Microencapsulation technology (taste masking & flavor)
  • 6.1.2 COMPLEMENTARY TECHNOLOGIES
    • 6.1.2.1 Coating technology
    • 6.1.2.2 Nutrient stabilization methods
    • 6.1.2.3 Flavor release systems
  • 6.1.3 ADJACENT TECHNOLOGIES
    • 6.1.3.1 3D-printing & personalized dosing platforms
    • 6.1.3.2 Plant-based and clean-label ingredient technologies
    • 6.1.3.3 Smart packaging
• 6.2 TECHNOLOGY/PRODUCT ROADMAP
  • 6.2.1 SHORT-TERM | FOUNDATION & EARLY COMMERCIALIZATION
  • 6.2.2 MID-TERM | EXPANSION & STANDARDIZATION
  • 6.2.3 LONG-TERM | PRECISION NUTRITION & SMART CALCIUM SOLUTIONS
• 6.3 PATENT ANALYSIS
• 6.4 FUTURE APPLICATIONS
  • 6.4.1 GELATIN-FREE, REDUCED-SUGAR FUNCTIONAL GUMMIES ENRICHED WITH PGH EXTRACT
  • 6.4.2 MICROENCAPSULATION OF VITAMIN C FOR IMPROVED STABILITY IN NUTRACEUTICAL GUMMIES
  • 6.4.3 3D-PRINTED PATIENT-TAILORED MEDICINAL GUMMIES FOR PEDIATRIC DRUG DELIVERY
  • 6.4.4 EDIBLE ACTIVE PACKAGING AS SMART PACKAGING FOR NUTRACEUTICAL GUMMIES
  • 6.4.5 IOT-ENABLED SMART MANUFACTURING AND ITS FUTURE APPLICATION IN NUTRACEUTICAL GUMMY PRODUCTION
• 6.5 IMPACT OF GENERATIVE AI ON NUTRACEUTICAL GUMMIES MARKET
  • 6.5.1 INTRODUCTION
  • 6.5.2 USE OF GENERATIVE AI ON NUTRACEUTICAL GUMMIES MARKET
  • 6.5.3 TOP USE CASES AND MARKET POTENTIAL
  • 6.5.4 BEST PRACTICES IN NUTRACEUTICAL INDUSTRY
  • 6.5.5 CASE STUDIES OF AI IMPLEMENTATION IN NUTRACEUTICAL GUMMIES MARKET
  • 6.5.6 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
  • 6.5.7 CLIENTS' READINESS TO ADOPT GENERATIVE AI NUTRACEUTICAL GUMMIES

7 REGULATORY LANDSCAPE AND SUSTAINABILITY INITIATIVES

• 7.1 REGIONAL REGULATIONS AND COMPLIANCE
  • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 7.1.2 INDUSTRY STANDARDS
  • 7.1.3 LABELING REQUIREMENTS AND CLAIMS
  • 7.1.4 ANTICIPATED REGULATORY CHANGES IN NEXT 5-10 YEARS
    • 7.1.4.1 Mandatory validation of bioavailability & functional claims
    • 7.1.4.2 Global harmonization of dietary supplement & nutraceutical classifications
    • 7.1.4.3 Strengthened safety, contaminant, & additive control regulations
    • 7.1.4.4 Digital labeling, traceability & QR-based compliance tracking
• 7.2 SUSTAINABILITY INITIATIVES
  • 7.2.1 SUSTAINABLE SOURCING
  • 7.2.2 CARBON FOOTPRINT REDUCTION INITIATIVES
  • 7.2.3 CIRCULAR ECONOMY APPROACHES
• 7.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES
• 7.4 CERTIFICATIONS, LABELING, ECO-STANDARDS

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

• 8.1 DECISION-MAKING PROCESS
• 8.2 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
  • 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 8.2.2 BUYING CRITERIA
• 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
• 8.4 UNMET NEEDS OF VARIOUS APPLICATION INDUSTRIES ACROSS SUPPLY CHAIN
• 8.5 MARKET PROFITABILITY
• 8.6 REVENUE POTENTIAL
  • 8.6.1 COST DYNAMICS
  • 8.6.2 MARGIN OPPORTUNITIES, BY TYPE

9 NUTRACEUTICAL GUMMIES MARKET, BY TYPE

• 9.1 INTRODUCTION
• 9.2 B2C MARKET
  • 9.2.1 ADVANCING CONSUMER HEALTH THROUGH FUNCTIONAL GUMMIES
• 9.3 B2B MARKET
  • 9.3.1 POWERING BRANDS WITH SCALABLE, SCIENCE-DRIVEN GUMMY SOLUTIONS

10 NUTRACEUTICAL GUMMIES MARKET (B2B), BY CUSTOMER TYPE

• 10.1 INTRODUCTION
• 10.2 BRAND OWNERS & MARKETING COMPANIES
  • 10.2.1 DEMAND FOR DIFFERENTIATED, CLEAN-LABEL, AND TREND-RESPONSIVE GUMMY FORMULATIONS TO BENEFIT CONTRACT MANUFACTURERS AND PRIVATE-LABEL PARTNERS
• 10.3 RETAILERS & DISTRIBUTORS
  • 10.3.1 RAPID EXPANSION OF PRIVATE-LABEL SUPPLEMENTS AND OMNICHANNEL RETAIL STRATEGIES TO INCREASE RETAILER DEMAND FOR COST-EFFICIENT, HIGH-QUALITY GUMMY MANUFACTURING PARTNERSHIPS
• 10.4 HEALTHCARE & WELLNESS
  • 10.4.1 GROWING INTEGRATION OF NUTRITION INTO PREVENTIVE CARE, PEDIATRICS, AND WELLNESS PROGRAMS TO DRIVE DEMAND FOR CLINICALLY CREDIBLE, COMPLIANCE-FRIENDLY GUMMY SUPPLEMENTS
• 10.5 PHARMACEUTICAL COMPANIES
  • 10.5.1 PHARMACEUTICAL PLAYERS LEVERAGE NUTRACEUTICAL GUMMIES TO EXTEND CONSUMER HEALTH PORTFOLIOS BEYOND PRESCRIPTIONS WHILE MAINTAINING CLINICAL CREDIBILITY AND QUALITY DIFFERENTIATION
• 10.6 FOOD & BEVERAGE COMPANIES
  • 10.6.1 CONVERGENCE OF INDULGENCE AND FUNCTIONALITY PROMPTING CONFECTIONERY AND FOOD COMPANIES TO EXPLORE FUNCTIONAL GUMMIES

11 NUTRACEUTICAL GUMMIES MARKET (B2B), BY PRODUCTION CAPACITY

• 11.1 INTRODUCTION
• 11.2 SMALL-SCALE CONTRACT MANUFACTURERS (<10 M UNITS/YEAR)
  • 11.2.1 GROWING DEMAND FOR LOW-VOLUME, CUSTOMIZED GUMMY FORMULATIONS TO SUPPORT EMERGING NUTRACEUTICAL BRANDS
• 11.3 MID-SCALE MANUFACTURERS (10-50 M UNITS/YEAR)
  • 11.3.1 INCREASING NEED FOR SCALABLE PRODUCTION WITH FORMULATION FLEXIBILITY TO SUPPORT BRAND EXPANSION AND REGIONAL MARKET PENETRATION
• 11.4 LARGE-SCALE INDUSTRIAL MANUFACTURERS (50+ M UNITS/YEAR)
  • 11.4.1 RISING REQUIREMENT FOR HIGH-VOLUME, STANDARDIZED GUMMY PRODUCTION TO ENSURE SUPPLY CONSISTENCY FOR GLOBAL NUTRACEUTICAL BRANDS

12 NUTRACEUTICAL GUMMIES MARKET (B2B), BY INGREDIENT SOURCE

• 12.1 INTRODUCTION
• 12.2 ANIMAL-BASED SOURCES
  • 12.2.1 COLLAGEN EFFICACY KEEPS ANIMAL-BASED INGREDIENTS DOMINANT
• 12.3 PLANT-BASED SOURCES
  • 12.3.1 VEGAN AND CLEAN-LABEL DEMAND FUELS PLANT-BASED ADOPTION
• 12.4 MICROBIAL/FERMENTATION-DERIVED SOURCES
  • 12.4.1 ADVANCEMENTS IN STABILIZED FERMENTATION TECHNOLOGIES TO EXPANDING ADOPTION OF MICROBIAL-DERIVED ACTIVES IN GUMMY FORMULATIONS
• 12.5 SYNTHETIC/CHEMICALLY-DERIVED SOURCES
  • 12.5.1 CONSISTENCY AND SCALE TO SUSTAIN SYNTHETIC INGREDIENT USAGE

13 NUTRACEUTICAL GUMMIES MARKET (B2B), BY GUMMY BASE/EXCIPIENTS

• 13.1 INTRODUCTION
• 13.2 GELATIN-BASED GUMMIES
  • 13.2.1 HIGH ACTIVE LOADING AND TEXTURE RELIABILITY TO CONTINUE DRIVING GELATIN USAGE
• 13.3 PECTIN-BASED GUMMIES
  • 13.3.1 VEGAN POSITIONING AND CLEAN-LABEL DEMAND TO ACCELERATE PECTIN ADOPTION
• 13.4 STARCH-BASED GUMMIES
  • 13.4.1 COST PRESSURE AND LARGE-SCALE PRODUCTION NEEDS TO SUSTAIN STARCH-BASED SYSTEMS
• 13.5 AGAR, CARRAGEENAN, AND OTHER HYDROCOLLOIDS

14 NUTRACEUTICAL GUMMIES MARKET (B2C), BY PRODUCT TYPE

• 14.1 INTRODUCTION
• 14.2 VITAMINS
  • 14.2.1 RISING INSTANCES OF VITAMIN DEFICIENCIES TO DRIVE SEGMENT
  • 14.2.2 MULTIVITAMINS
  • 14.2.3 VITAMIN C
  • 14.2.4 VITAMIN D
  • 14.2.5 VITAMIN B COMPLEX
  • 14.2.6 VITAMIN E AND A
• 14.3 MINERALS
  • 14.3.1 MEETING ESSENTIAL MINERAL NEEDS THROUGH CONVENIENT, PALATABLE SUPPLEMENTATION FOR EVERYDAY HEALTH SUPPORT
  • 14.3.2 CALCIUM
  • 14.3.3 IRON
  • 14.3.4 ZINC
  • 14.3.5 MAGNESIUM
• 14.4 OMEGA-3 FATTY ACIDS
• 14.5 PROBIOTICS & PREBIOTICS
  • 14.5.1 INCREASED INTEREST IN SKIN CARE AMONG CONSUMERS TO BOOST MARKET
• 14.6 COLLAGEN & BEAUTY-FROM-WITHIN
  • 14.6.1 INCREASED INTEREST IN SKIN CARE AMONG CONSUMERS TO BOOST MARKET
• 14.7 HERBAL & BOTANICAL
  • 14.7.1 RISING CONSUMER PREFERENCE FOR PLANT-BASED NATURAL INGREDIENTS TO DRIVE SEGMENT
  • 14.7.2 ASHWAGANDHA
  • 14.7.3 TURMERIC/CURCUMIN
  • 14.7.4 ELDERBERRY
  • 14.7.5 MELATONIN
  • 14.7.6 OTHER HERBAL AND BOTANICAL GUMMIES
• 14.8 DIETARY FIBER
• 14.9 CBD & CANNABIS-DERIVED
• 14.10 SPECIALTY FORMULATIONS
  • 14.10.1 HEALTH-PROMOTING PROPERTIES TO AUGMENT SEGMENT GROWTH

15 NUTRACEUTICAL GUMMIES MARKET(B2C), BY FUNCTIONALITY

• 15.1 INTRODUCTION
• 15.2 IMMUNITY SUPPORT
  • 15.2.1 RISING FOCUS ON IMPROVING IMMUNITY TO DRIVE MARKET
• 15.3 GENERAL HEALTH & WELLNESS
  • 15.3.1 GROWING NUTRITIONAL DEFICIENCIES AND PREVENTIVE HEALTHCARE TRENDS TO DRIVE MARKET
• 15.4 BONE & JOINT HEALTH
  • 15.4.1 RISING CASES OF OSTEOPOROSIS TO PROPEL MARKET GROWTH
• 15.5 WEIGHT MANAGEMENT
  • 15.5.1 RISING PREVALENCE OF OBESITY AND METABOLIC DISORDERS TO DRIVE MARKET
• 15.6 BEAUTY & SKIN HEALTH
  • 15.6.1 INCREASING FOCUS ON APPEARANCE AND OVERALL SKIN WELLNESS TO DRIVE MARKET

16 NUTRACEUTICAL GUMMIES MARKET (B2C), BY DEMOGRAPHICS

• 16.1 INTRODUCTION
• 16.2 GENERATION ALPHA (0-12 YEARS)
  • 16.2.1 EARLY-LIFE SUPPLEMENTATION AND DIGITAL-FIRST PARENTING TO FUEL DEMAND FOR PEDIATRIC NUTRACEUTICAL GUMMIES
• 16.3 GENERATION Z (13-28 YEARS)
  • 16.3.1 FOCUS ON HEALTH AND DAILY SELF-CARE TO FUEL GUMMY SUPPLEMENT DEMAND
• 16.4 MILLENNIALS (GEN Y) (29-44 YEARS)
  • 16.4.1 LIFESTYLE-DRIVEN WELLNESS CHOICES TO POWER NUTRACEUTICAL ADOPTION
• 16.5 GENERATION X (45-60 YEARS)
  • 16.5.1 WILLINGNESS TO INVEST IN HEALTH-ENHANCING NUTRITION SOLUTIONS TO DRIVE MARKET
• 16.6 BABY BOOMERS AND OLDER (61+ YEARS)
  • 16.6.1 HEALTHY AGING PRIORITIES TO DRIVE NUTRACEUTICAL USE

17 NUTRACEUTICAL GUMMIES MARKET (B2C), BY DISTRIBUTION CHANNEL

• 17.1 INTRODUCTION
• 17.2 OFFLINE CHANNELS
  • 17.2.1 HYPERMARKETS & SUPERMARKETS
    • 17.2.1.1 Preferred purchasing destination and availability of variants to drive growth
  • 17.2.2 PHARMACIES & DRUGSTORES
    • 17.2.2.1 Wide presence and around-the-clock services to drive growth
  • 17.2.3 SPECIALTY HEALTH STORES
    • 17.2.3.1 Enabling premium and targeted gummy supplement sales
  • 17.2.4 CONVENIENCE STORES
    • 17.2.4.1 Preference toward specialized healthcare products to fuel growth
  • 17.2.5 MASS MERCHANDISERS AND MULTI-LEVEL MARKETING (MLM)
    • 17.2.5.1 High-volume retail and network-based selling drive offline expansion
• 17.3 ONLINE CHANNELS

18 NUTRACEUTICAL GUMMIES MARKET, BY REGION

• 18.1 INTRODUCTION
• 18.2 NORTH AMERICA
  • 18.2.1 US
    • 18.2.1.1 Presence of key players and various health trends to boost market
  • 18.2.2 CANADA
    • 18.2.2.1 Convenience, taste, and health benefits to drive demand for nutraceutical gummies
  • 18.2.3 MEXICO
    • 18.2.3.1 Rising health-conscious and vegan population to drive market
• 18.3 EUROPE
  • 18.3.1 GERMANY
    • 18.3.1.1 Growing interest in health & wellness to drive market
  • 18.3.2 UK
    • 18.3.2.1 Rising prevalence of diseases to drive market
  • 18.3.3 FRANCE
    • 18.3.3.1 High healthcare costs and increased demand for dietary supplements to drive market
  • 18.3.4 SPAIN
    • 18.3.4.1 Adoption of healthy lifestyles to drive market
  • 18.3.5 ITALY
    • 18.3.5.1 Strong e-commerce system and rising geriatric population to drive market
  • 18.3.6 REST OF EUROPE
• 18.4 ASIA PACIFIC
  • 18.4.1 CHINA
    • 18.4.1.1 Large population and increasing prevalence of diseases to drive market
  • 18.4.2 JAPAN
    • 18.4.2.1 Rising awareness and shifting preferences toward dietary supplements to drive market
  • 18.4.3 INDIA
    • 18.4.3.1 Rising disposable incomes and growing focus on wellness to drive market
  • 18.4.4 AUSTRALIA & NEW ZEALAND
    • 18.4.4.1 High demand for dietary supplements, particularly in new formats, to drive market
  • 18.4.5 REST OF ASIA PACIFIC
• 18.5 SOUTH AMERICA
  • 18.5.1 BRAZIL
    • 18.5.1.1 Increasing consumer preference for convenient and palatable formats in nutrient intake to drive market
  • 18.5.2 ARGENTINA
    • 18.5.2.1 Growing focus on prevention of micronutrient deficiencies and cardiometabolic risks to drive market
  • 18.5.3 REST OF SOUTH AMERICA
• 18.6 REST OF THE WORLD
  • 18.6.1 MIDDLE EAST
    • 18.6.1.1 Rising disposable incomes and healthcare costs to drive market
  • 18.6.2 AFRICA
    • 18.6.2.1 Increase in vitamin deficiency and consumer awareness about health supplements to fuel market

19 COMPETITIVE LANDSCAPE

• 19.1 OVERVIEW
• 19.2 B2C PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2020-2025
• 19.3 REVENUE ANALYSIS (B2C MARKET), 2022-2024
• 19.4 MARKET SHARE ANALYSIS (B2C MARKET), 2024
• 19.5 MARKET SHARE ANALYSIS (B2B MARKET), 2024
• 19.6 BRAND/PRODUCT COMPARISON
• 19.7 COMPANY EVALUATION MATRIX: B2C COMPANIES, 2024
  • 19.7.1 STARS
  • 19.7.2 EMERGING LEADERS
  • 19.7.3 PERVASIVE PLAYERS
  • 19.7.4 PARTICIPANTS
  • 19.7.5 COMPANY FOOTPRINT: B2C NUTRACEUTICAL GUMMIES COMPANIES, 2024
    • 19.7.5.1 Company footprint
    • 19.7.5.2 Regional footprint
    • 19.7.5.3 Product type footprint
    • 19.7.5.4 Functionality footprint
• 19.8 COMPANY EVALUATION MATRIX: B2B COMPANIES, 2024
  • 19.8.1 STARS
  • 19.8.2 EMERGING LEADERS
  • 19.8.3 PERVASIVE PLAYERS
  • 19.8.4 PARTICIPANTS
  • 19.8.5 COMPETITIVE BENCHMARKING
    • 19.8.5.1 Detailed list of B2B key players
  • 19.8.6 COMPETITIVE BENCHMARKING: B2B COMPANIES, 2024
    • 19.8.6.1 Competitive benchmarking of key B2B companies
• 19.9 COMPANY VALUATION AND FINANCIAL METRICS
• 19.10 COMPETITIVE SCENARIO
  • 19.10.1 PRODUCT LAUNCHES
  • 19.10.2 DEALS
  • 19.10.3 EXPANSIONS
  • 19.10.4 OTHER DEVELOPMENTS

20 COMPANY PROFILES

• 20.1 B2C PLAYERS (BRAND MANUFACTURERS)
  • 20.1.1 CHURCH & DWIGHT CO., INC.
    • 20.1.1.1 Business overview
    • 20.1.1.2 Products/Solutions/Services offered
    • 20.1.1.3 Recent developments
      • 20.1.1.3.1 Product launches
    • 20.1.1.4 MnM view
      • 20.1.1.4.1 Key strengths
      • 20.1.1.4.2 Strategic choices
      • 20.1.1.4.3 Weaknesses and competitive threats
  • 20.1.2 H&H GROUP
    • 20.1.2.1 Business overview
    • 20.1.2.2 Products/Solutions/Services offered
    • 20.1.2.3 Recent developments
      • 20.1.2.3.1 Deals
      • 20.1.2.3.2 Expansions
      • 20.1.2.3.3 Other developments
    • 20.1.2.4 MnM view
      • 20.1.2.4.1 Key strengths
      • 20.1.2.4.2 Strategic choices
      • 20.1.2.4.3 Weaknesses and competitive threats
  • 20.1.3 AMWAY
    • 20.1.3.1 Business overview
    • 20.1.3.2 Products/Solutions/Services offered
    • 20.1.3.3 Recent developments
      • 20.1.3.3.1 Product launches
      • 20.1.3.3.2 Deals
    • 20.1.3.4 MnM view
      • 20.1.3.4.1 Key strengths
      • 20.1.3.4.2 Strategic choices
      • 20.1.3.4.3 Weaknesses and competitive threats
  • 20.1.4 BAYER AG
    • 20.1.4.1 Business overview
    • 20.1.4.2 Products/Solutions/Services offered
    • 20.1.4.3 Recent developments
      • 20.1.4.3.1 Product launches
    • 20.1.4.4 MnM view
      • 20.1.4.4.1 Key strengths
      • 20.1.4.4.2 Strategic choices
      • 20.1.4.4.3 Weaknesses and competitive threats
  • 20.1.5 HALEON GROUP OF COMPANIES
    • 20.1.5.1 Business overview
    • 20.1.5.2 Products/Solutions/Services offered
    • 20.1.5.3 Recent developments
      • 20.1.5.3.1 Product launches
      • 20.1.5.3.2 Deals
      • 20.1.5.3.3 Expansions
    • 20.1.5.4 MnM view
      • 20.1.5.4.1 Key strengths
      • 20.1.5.4.2 Strategic choices
      • 20.1.5.4.3 Weaknesses and competitive threats
  • 20.1.6 NESTLE
    • 20.1.6.1 Business overview
    • 20.1.6.2 Products/Solutions/Services offered
    • 20.1.6.3 Recent developments
      • 20.1.6.3.1 Product launches
      • 20.1.6.3.2 Deals
    • 20.1.6.4 MnM view
      • 20.1.6.4.1 Key strengths
      • 20.1.6.4.2 Strategic choices
      • 20.1.6.4.3 Weaknesses and competitive threats
  • 20.1.7 UNILEVER
    • 20.1.7.1 Business overview
    • 20.1.7.2 Products/Solutions/Services offered
    • 20.1.7.3 Recent developments
      • 20.1.7.3.1 Product launches
      • 20.1.7.3.2 Deals
      • 20.1.7.3.3 Expansions
    • 20.1.7.4 MnM view
      • 20.1.7.4.1 Key strengths
      • 20.1.7.4.2 Strategic choices
      • 20.1.7.4.3 Weaknesses and competitive threats
  • 20.1.8 OTSUKA HOLDINGS CO., LTD.
    • 20.1.8.1 Business overview
    • 20.1.8.2 Products/Solutions/Services offered
    • 20.1.8.3 Recent developments
      • 20.1.8.3.1 Product launches
      • 20.1.8.3.2 Expansions
    • 20.1.8.4 MnM view
      • 20.1.8.4.1 Key strengths
      • 20.1.8.4.2 Strategic choices
      • 20.1.8.4.3 Weaknesses and competitive threats
  • 20.1.9 PHARMACARE LABORATORIES
    • 20.1.9.1 Business overview
    • 20.1.9.2 Products/Solutions/Services offered
    • 20.1.9.3 Recent developments
      • 20.1.9.3.1 Expansions
    • 20.1.9.4 MnM view
  • 20.1.10 SWANSON
    • 20.1.10.1 Business overview
    • 20.1.10.2 Products/Solutions/Services offered
    • 20.1.10.3 Recent developments
      • 20.1.10.3.1 Product launches
    • 20.1.10.4 MnM view
  • 20.1.11 IM HEALTHCARE
    • 20.1.11.1 Business overview
    • 20.1.11.2 Products/Solutions/Services offered
    • 20.1.11.3 Recent developments
    • 20.1.11.4 MnM view
  • 20.1.12 SMP NUTRA
    • 20.1.12.1 Business overview
    • 20.1.12.2 Products/Solutions/Services offered
    • 20.1.12.3 Recent developments
    • 20.1.12.4 MnM view
  • 20.1.13 NATURE'S TRUTH
    • 20.1.13.1 Business overview
    • 20.1.13.2 Products/Solutions/Services offered
    • 20.1.13.3 Recent developments
      • 20.1.13.3.1 Other developments
    • 20.1.13.4 MnM view
  • 20.1.14 HERBALAND NATURALS INC.
    • 20.1.14.1 Business overview
    • 20.1.14.2 Products/Solutions/Services offered
    • 20.1.14.3 Recent developments
    • 20.1.14.4 MnM view
  • 20.1.15 BOSCOGEN, INC.
    • 20.1.15.1 Business overview
    • 20.1.15.2 Products/Solutions/Services offered
    • 20.1.15.3 Recent developments
    • 20.1.15.4 MnM view
• 20.2 B2B PLAYERS (CONTRACT MANUFACTURERS)
  • 20.2.1 SOFGEN PHARMA
    • 20.2.1.1 Business overview
    • 20.2.1.2 Products/Services/Solutions offered
    • 20.2.1.3 Recent developments
      • 20.2.1.3.1 Expansions
    • 20.2.1.4 MnM view
      • 20.2.1.4.1 Key strengths
      • 20.2.1.4.2 Strategic choices
      • 20.2.1.4.3 Weaknesses & competitive threats
  • 20.2.2 CATALENT, INC.
    • 20.2.2.1 Business overview
    • 20.2.2.2 Products/Services/Solutions offered
    • 20.2.2.3 Recent developments
      • 20.2.2.3.1 Deals
    • 20.2.2.4 MnM view
      • 20.2.2.4.1 Key strengths
      • 20.2.2.4.2 Strategic choices
      • 20.2.2.4.3 Weaknesses & competitive threats
  • 20.2.3 ACTIV'INSIDE
    • 20.2.3.1 Business overview
    • 20.2.3.2 Products/Services/Solutions offered
    • 20.2.3.3 Recent developments
    • 20.2.3.4 MnM view
      • 20.2.3.4.1 Key strengths
      • 20.2.3.4.2 Strategic choices
      • 20.2.3.4.3 Weaknesses & competitive threats
  • 20.2.4 SIRIO PHARMA CO., LTD.
    • 20.2.4.1 Business overview
    • 20.2.4.2 Products/Services/Solutions offered
    • 20.2.4.3 Recent developments
      • 20.2.4.3.1 Product launches
    • 20.2.4.4 MnM view
  • 20.2.5 WIN NUTRA
    • 20.2.5.1 Business overview
    • 20.2.5.2 Products/Services/Solutions offered
    • 20.2.5.3 Recent developments
    • 20.2.5.4 MnM view
  • 20.2.6 MAKERS NUTRITION, LLC
    • 20.2.6.1 Business overview
    • 20.2.6.2 Products/Services/Solutions offered
    • 20.2.6.3 Recent developments
    • 20.2.6.4 MnM view
  • 20.2.7 ION LABS
    • 20.2.7.1 Business overview
    • 20.2.7.2 Products/Services/Solutions offered
    • 20.2.7.3 Recent developments
      • 20.2.7.3.1 Expansions
      • 20.2.7.3.2 Deals
    • 20.2.7.4 MnM view
  • 20.2.8 VITAJOY GROUP
    • 20.2.8.1 Business overview
    • 20.2.8.2 Products/Services/Solutions offered
    • 20.2.8.3 Recent developments
    • 20.2.8.4 MnM view
  • 20.2.9 BLISS LIFESCIENCES LLP
    • 20.2.9.1 Business overview
    • 20.2.9.2 Products/Services/Solutions offered
    • 20.2.9.3 Recent developments
    • 20.2.9.4 MnM view
  • 20.2.10 GLOBAL WIDGET
    • 20.2.10.1 Business overview
    • 20.2.10.2 Products/Services/Solutions offered
    • 20.2.10.3 Recent developments
      • 20.2.10.3.1 Product launches
      • 20.2.10.3.2 Deals
      • 20.2.10.3.3 Expansions
    • 20.2.10.4 MnM view
  • 20.2.11 GUMMY WORLDS
  • 20.2.12 TOPGUM
  • 20.2.13 MERICAL
  • 20.2.14 FERMENTIS LIFE SCIENCES
  • 20.2.15 EAGLE LABS, INC.

21 RESEARCH METHODOLOGY

• 21.1 RESEARCH DATA
  • 21.1.1 SECONDARY DATA
    • 21.1.1.1 Key data from secondary sources
  • 21.1.2 PRIMARY DATA
    • 21.1.2.1 Key industry insights
    • 21.1.2.2 Breakdown of primary interviews
    • 21.1.2.3 Primary sources
• 21.2 MARKET SIZE ESTIMATION
  • 21.2.1 NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: SUPPLY SIDE
  • 21.2.2 NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: DEMAND SIDE
  • 21.2.3 NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • 21.2.4 NUTRACEUTICAL GUMMIES MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
• 21.3 DATA TRIANGULATION
• 21.4 RESEARCH ASSUMPTIONS
• 21.5 RESEARCH LIMITATIONS

22 ADJACENT & RELATED MARKETS

• 22.1 INTRODUCTION
• 22.2 LIMITATIONS
• 22.3 NUTRACEUTICAL INGREDIENTS MARKET
  • 22.3.1 MARKET DEFINITION
  • 22.3.2 MARKET OVERVIEW
• 22.4 DIETARY SUPPLEMENTS MARKET
  • 22.4.1 MARKET DEFINITION
  • 22.4.2 MARKET OVERVIEW

23 APPENDIX

• 23.1 DISCUSSION GUIDE
• 23.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 23.3 CUSTOMIZATION OPTIONS
• 23.4 RELATED REPORTS
• 23.5 AUTHOR DETAILS